Cigna Group Delivers Q3 Beat as 2027 Outlook Takes Shape, RBC Says

MT Newswires Live
11/19

Cigna Group's (CI) Q3 beat was driven by solid performance in Cigna Healthcare and continued momentum in Specialty and Care Services, RBC Capital Markets said in a note Wednesday.

Following the results, management expressed confidence in achieving at least 10% adjusted earnings per share growth from an about $30 base, adjusted for its exit from the Affordable Care Act, or ACA, exchange market, the analysts said.

The analysts said they are raising their 2026 adjusted EPS estimate to $30.66 from $30.49. However, they lowered their 2027 adjusted EPS estimate to $33.04 from $33.53.

The analysts added that this reduction mainly reflects stranded overhead costs from Cigna's ACA market exit and softer Evernorth margins due to smaller rebate pools and lower employer coverage of GLP-1 weight-loss drugs.

RBC raised its price target on Cigna to $346 from $337 while keeping its outperform rating.

Price: 271.94, Change: -13.44, Percent Change: -4.71

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10